alcami corp.inc.

Activity value 61 united states Buyer,Last transaction date: 2023-07-18

Overview
Import data
Partners
HS Codes
Products
Areas
Ports

Trade trend analysis

Mon | Year

Number of Transactions Quantity Weight

The above chart presents the market trend analysis for alcami corp.inc. from 2023 to 2024. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.

Year Transactions Quantity Weight
2023 1 8 0
2024 0 0 0

Bill of lading data

< 1/4 >

Trade date 2023/07/18 B/L No. kxajx2pyybxj9
Suppliers genesys biologics pvt ltd. Buyers alcami corp.inc.
POLs hyderabad PODs ——
Supply area India Purchas area United States
Weight —— Amount 1204.227
Hs code 30043110 Product tags lispro,insulin
Product description INSULIN LISPRO R-DNA Expand

Trade date 2022/07/22 B/L No. yjthhxrm93qt7
Suppliers genesys biologics pvt ltd. Buyers alcami corp.inc.
POLs hyderabad PODs ——
Supply area India Purchas area United States
Weight —— Amount 152.478
Hs code 30043110 Product tags insulin glargine,formulation
Product description FORMULATION BULK OF INSULIN GLARGINE (DP Expand

Trade date 2022/07/22 B/L No. yjthhxrm93qt7
Suppliers genesys biologics pvt ltd. Buyers alcami corp.inc.
POLs hyderabad PODs ——
Supply area India Purchas area United States
Weight —— Amount 152.478
Hs code 30043110 Product tags insulin glargine,formulation
Product description FORMULATION BULK OF INSULIN GLARGINE (LL Expand

Trade date 2022/07/22 B/L No. yjthhxrm93qt7
Suppliers genesys biologics pvt ltd. Buyers alcami corp.inc.
POLs hyderabad PODs ——
Supply area India Purchas area United States
Weight —— Amount 152.478
Hs code 30043110 Product tags insulin glargine,formulation
Product description FORMULATION BULK OF INSULIN GLARGINE (DS Expand

Partners

Total 1

Rank Company Transactions Per Detail
1 genesys biologics pvt ltd. indiabuyer,they trade on 2023-07-18 4 100.00% >

Products

Total 4

Products Transactions Per Detail
formulation
3 75% >
insulin glargine
3 75% >
insulin
1 25% >
lispro
1 25% >

Hscode rank

Total 0

HSCode Name Transactions Per Detail
HS 30043110 4 100% >

Trading Area

Total 1

Area Transactions Per Detail
india 4 100.00% >

alcami corp.inc. is united states Buyer, and primarily engages in the import and export business of products such as formulation，insulin glargine，insulin. According to the 52wmb.com global trade database, as of 2023-07-18, the company has completed 4 international trades, with its main trading regions covering india etc. The core products include HS30043110 etc, and its main trading partners are genesys biologics pvt ltd.. These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing. They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.

The trade data displayed on alcami corp.inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info

Email Hunting Tool

Employee emails